Isolation of Oleanolic Acid from Parinari curatellifolia (Planch Ex. Benth) Stem Bark and Evaluation of its Anticonvulsant and Sedative activities in Rodents
doi.org/10.26538/tjnpr/v3i1.4
Keywords:
Anticonvulsant,, Acute toxicity,, Oleanolic acid,, Parinari curatellifolia,, Sedative,, Pentylenetetrazole.Abstract
Parinari curatellifolia is used by traditional medicine practitioners for the treatment of epilepsy. So far, no study has isolated the active principle that may be responsible for its anticonvulsant activity. The study aimed to isolate compound(s) present from Parinari curatellifolia that may be responsible for its anticonvulsant activity. The ethyl acetate fraction of the stem bark of Parinari
curatellifolia was chromatographed over silica gel column chromatography which led to the isolation of compound C. The structure of the compound was elucidated using IR, 1H-NMR, 13CNMR and DEPT-135 spectroscopy. Acute toxicity study of the isolated compound was evaluated in mice using OECD 425 guidelines (2000 mg/kg orally). The anticonvulsant study of the isolated compound (at 50, 75 and 100 mg/kg) was evaluated in mice using pentylenetetrazole (PTZ)- induced convulsion. The sedative properties of the compound (at 10, 50 and 100 mg/kg) were evaluated using the diazepam-induced sleep model in rats. Structure elucidation of the isolated
compound confirmed the compound to be oleanolic acid. Acute toxicity study revealed no lethal effects at 2000 mg/kg. the compound (oleanolic acid) significantly (p<0.05) increased the onset of seizure at all doses and resulted in 25% protection against seizure at 100 mg/kg. It exerted sedative effect at all doses by significantly (p<0.05) reducing sleep latency and increasing total duration of sleep induced by diazepam. The results obtained from this study have revealed the presence of oleanolic acid in P. curatellifolia and have shown its anticonvulsant and sedative activities for the first time.
References
Alexopoulous AV. Pharmacoresistant epilepsy: Definition and explanation. Epileptol. 2013; 1:38-42.
Sasa MA. New Frontier in Epilepsy: Novel Antiepileptogenic Drugs. J Pharmacol Sci. 2006; 100:487-494.
Loscher W and Schmidt D. New horizons in the development of antiepileptic drugs. Epilep Res. 2002; 50:3-16.
Scharfman HE. The Neurobiology of Epilepsy. Curr. Neurol and Neurosci Rep. 2007; 7:348–354.
Uys AC, Malan SF, vanDyck S, van Zyl RL. Antimalarial compounds from Parinari capensis. Bioorg Med Chem Lett.2002; 12:2167.
Ssegawa P and Kasenene JM. Medicinal plant diversity and uses in the Sango bay area, Southern Uganda. J. Ethnopharmacol. 2007; 113:521-540.
Pedersen ME, Vestergaard HT, Hansen SL, Bah S, Diallo D,Jäger AK. Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions. J. Ethnopharmacol. 2009; 121:472-475.
Kraft C, Jenett-Siems K, Siems K, Jakupovic J, Mavis S, Bienzle U, Eich E. In-Vitro anti-plasmodial Evaluation of Medicinal Plants from Zimbabwe. Phytother Res. 2003; 2:123-128.
Halilu ME, October N, Balogun M, Musa KY, Abubakar MS. Isolation and Characterization of Triterpenes from Petroleum Ether and Ethyl acetate Extracts of Stem Bark of Parinari curatellifolia (Planch Ex. Benth) Chrysobalanaceae. Chem and Mater Res. 2013a; 3:100-107.
Singh GB, Singh S, Bani S, Gupta BD, Banerjee SK. Antiinflammatory activity of oleanolic acid in rats and mice. J Pharm Pharmacol. 1992; 44:456-458.
Ogbonnia SO, Sunday OO, Emmanuel NA, Veronica NE,Olawale OP. Evaluation of acute toxicity in mice and subchronic toxicity of hydroethanolic extract of Parinari curatellifolia (Chrysobalanaceae) seeds in rats. Afr J Biotechnol. 2009; 8:1800-1806.
Halilu ME, October N, Balogun M, Namrita L, Abubakar MS. Studies of In vitro Antioxidant and Cytotoxic Activities of Extracts and Isolated Compounds from Parinari curatellifolia (Chrysobalanaceae). J Nat Sci Res. 2013b; 3(13):149 – 154.
Organization for Economic Development. Principles of Good Laboratory Practice, In: hand book of Good Laboratory Practice (GLP) TDR, PRD/GLP/ 2008; 01:2.
NgoBum E, Schmutz M, Meyer C, Rakotonirina A, Bopelet M. Anticonvulsant properties of the methanolic extract of Cyperus articulates (Cyperaceae). J Ethnopharmacol. 2001; 76:145-150.
Wambebe C. Influence of some agents that affect 5-hydroxytryptamine metabolism and receptors on nitrazepam-induced sleep in mice. Br J Pharmacol. 1985; 84:185–191.
Ghias U, Waliullah B, Shaheen S, Muhammad A, Anwar S, Ashfaq A, Ala U. Chemical Constituents and Phytotoxicityof Solvent Extracted Fractions of Stem Bark of Grewiaoptiva Drummond ex Burret. Middle-East J Sci Res. 2011; 8:85-91.
Narendra V and Ameeta A. Isolation and Characterization of Oleanolic Acid from Roots of Lantana Camara. Asian J Pharm Clin Res. 2014; 7:189-191.
Gohari AR, Saeidnia S, Hadjiakhoondi A, Abdoullahi M,Nezafati M. Isolation and Quantificative Analysis of Oleanolic Acid from Saturejamutica (Fisch. & C. A. Mey). J Med Plants 2009; 8: 65-69.
Onoja E and Ndukwe IG. Isolation of oleanolic acid from chloroform extract of Borreria stachydea (DC) (Hutch. and Dalziel). J Nat Prod Plant Resourc. 2013; 3:57-60.
White HS. Clinical significance of animal models and mechanism of action studies of potential antiepileptic drugs. Epilepsia 1997; 38(Suppl. 1):S9-S17.
Rang HP, Dale MM, Ritter JM, Flower RJ. Antiepileptic drugs. Rang and Dale's Pharmacology. 6th ed. Elsevier: Churchill Livingstone 2007. 575–586 p.
Loscher W and Schmidt D. Which animal model should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilep Res. 1988; 2:145-181.
Amole OO, Yemitan OK, Oshokiyo K. Anticonvulsant activity of Rauwolvia vomitoria (Afzel). Afr J Pharm Pharmacol. 2009; 3:319-322.
Akah PA, Okoli CO, Ndu OO. Experimental methods in physiology and pharmacology. 2nd ed. Enugu, Nigeria: ABIC Books and Equip. Ltd. 2007. 161–162 p
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
